A groundbreaking Nature study reports researchers have used CRISPR gene editing technology to correct a mutation that causes hypertrophic cardiomyopathy in embryos. The technique also prevents the mutation from passing to future generations.
A new study reveals a defective version of astrocytes may be linked to the build up of alpha synuclein and could spur Parkinson's disease. The findings show the important role glial cells play in Parkinson's and offers insights into new targets for therapies to fight the neurodegenerative disease.
Researchers use CRISPR to convert cells isolated from mouse connective tissue into neural cells.
Researchers have developed a new protein that can alter DNA in living cells with much higher precision than current methods.
A newly developed approach could be used to treat Duchenne muscular dystrophy, researchers believe.
A new study confirms a mutation caused dysfunction associated with Alzheimer's and proposes a new therapeutic target.
A new study has identified a biological pathway associated with the risk for developing an eating disorder.